Author: Liu, Yuan-yuan; Chen, Liang-jun; Zhong, Yan; Shen, Meng-xin; Ma, Nian; Liu, Bing-yu; Luo, Fan; Hou, Wei; Yang, Zhan-qiu; Xiong, Hai-rong
Title: Specific interference shRNA-expressing plasmids inhibit Hantaan virus infection in vitro and in vivo Document date: 2016_3_14
ID: pwlybr2h_6
Snippet: Vero-E6 cells were obtained from the China Center for Type Culture Collection (CCTCC) and maintained in DMEM supplemented with 10% fetal bovine serum (FBS, GIBCO, Carlsbad, CA, USA), 0.1% L-glutamine, 100 U/mL penicillin and streptomycin. DMEM containing 2% FBS was used to maintain the medium after viral infection. The stocks of Hantaan virus strain 76-118 were obtained from the Institute of Virology of the Chinese Academy of Preventive Medicine .....
Document: Vero-E6 cells were obtained from the China Center for Type Culture Collection (CCTCC) and maintained in DMEM supplemented with 10% fetal bovine serum (FBS, GIBCO, Carlsbad, CA, USA), 0.1% L-glutamine, 100 U/mL penicillin and streptomycin. DMEM containing 2% FBS was used to maintain the medium after viral infection. The stocks of Hantaan virus strain 76-118 were obtained from the Institute of Virology of the Chinese Academy of Preventive Medicine (Beijing, China) and were propagated in Vero-E6 cells. HTNV titration was performed regularly based on indirect immunofluorescence assay (IFA) as described previously [18] . The TCID 50 was determined to be 10 6 /0.1 mL.
Search related documents:
Co phrase search for related documents- bovine serum and immunofluorescence assay: 1, 2, 3, 4
- bovine serum and indirect immunofluorescence assay: 1
- bovine serum and medium maintain: 1
- bovine serum and viral infection: 1, 2, 3, 4, 5, 6, 7, 8
- fetal bovine serum and immunofluorescence assay: 1, 2, 3
- fetal bovine serum and indirect immunofluorescence assay: 1
- fetal bovine serum and medium maintain: 1
- fetal bovine serum and viral infection: 1, 2, 3, 4, 5
- Hantaan virus and immunofluorescence assay: 1
- Hantaan virus and viral infection: 1, 2, 3, 4
- IFA indirect immunofluorescence assay and immunofluorescence assay: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33
- IFA indirect immunofluorescence assay and indirect immunofluorescence assay: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33
- IFA indirect immunofluorescence assay and viral infection: 1, 2
- immunofluorescence assay and indirect immunofluorescence assay: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- immunofluorescence assay and viral infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
- indirect immunofluorescence assay and viral infection: 1, 2, 3, 4, 5, 6, 7
- previously describe and viral infection: 1, 2
Co phrase search for related documents, hyperlinks ordered by date